2 Result: Biophytis
Biophytis Gains Momentum; bluebird bio Posts Mixed Results
August 08th, 2023
Shares of Biophytis S.A. (Nasdaq: BPTS) surged over 10% in pre-market trading as the company secured a favorable opinion from Belgian authorities for its groundbreaking SARA-31 program. This initiative marks the first-ever phase 3 study targ. Read more
Breaking: Novartis Q2 Earnings Beat; Sarconeos Deal Boosts Biophytis
July 18th, 2023
Shares of Novartis AG (NYSE: NVS) experienced a surge in premarket trading as the company surpassed expectations in its second-quarter 2023 financial report. The pharmaceutical giant reported core earnings per share (EPS) of $1.83 and sales . Read more
Want To Find Some News?
News By Industries
Recent Post
-
Earnings Countdown: Lockheed Martin, Stryker, and PACCAR Gear Up
January 26th, 2025Earnings Spotlight: SoFi Technologies, Sanmina, and Nucor Set to Report
January 26th, 2025Global Flag Football League Plans To Host Pro Flag Football Tournament in Las Vegas
January 23rd, 2025Earnings On Deck: Netflix, United Airlines, and Agilysys Gear Up
January 19th, 2025
Member Login